Lucknow News Flash

Hyderabad, India – 8 october 2026, According to Mordor Intelligence, the blood glucose monitoring market size is estimated at USD 31.61 billion in 2026 and is expected to reach USD 51.26 billion by 2031, registering a CAGR of 10.15% during the forecast period. North America currently holds the largest share of the market, while Asia-Pacific is projected to be the fastest-growing regional market.

The global blood glucose monitoring market covers self-monitoring blood glucose meters, test strips, lancets, and continuous glucose monitoring systems, including sensors, transmitters, and receivers used for personal or clinical diabetes management. The market is benefiting from the shift toward continuous and connected monitoring, rising diabetes prevalence, wearable sensor development, greater integration with digital health platforms, and expanding reimbursement for glucose monitoring technologies.

Report Overview: https://www.mordorintelligence.com/industry-reports/global-blood-glucose-monitoring-market-industry?utm_source=abnewswire

 

Blood Glucose Monitoring Market Trends

Accelerating Shift Toward Continuous Glucose Monitoring

The shift from intermittent self-monitoring blood glucose toward continuous glucose monitoring is one of the strongest trends shaping the blood glucose monitoring industry. CGM systems provide continuous glucose readings and alerts, allowing patients and healthcare providers to make more informed decisions regarding insulin management, diet, and physical activity.

Growing reimbursement coverage is supporting CGM adoption, particularly in North America and other developed healthcare markets. The integration of CGM systems with smartphones, smartwatches, insulin pumps, and digital health applications is also making glucose monitoring more convenient and connected.

Rising Diabetes Prevalence Expands Monitoring Demand

The growing global diabetes burden is expanding the addressable population for blood glucose monitoring products. Earlier screening programs in emerging economies are also bringing more patients into formal diabetes management, supporting demand for both conventional glucose meters and connected monitoring technologies.

The opportunity is particularly relevant across Asia-Pacific, where large diabetic populations and expanding healthcare infrastructure are supporting demand. Manufacturers offering affordable monitoring solutions can benefit as healthcare systems seek to improve diagnosis, monitoring, and long-term disease management.

Wearable Sensor Development Improves Patient Convenience

Miniaturization of glucose sensors is supporting the development of smaller, more discreet, and more comfortable monitoring devices. Advances in sensor design, wearable electronics, and data-processing capabilities are allowing manufacturers to extend wear duration and improve the overall user experience.

Research into minimally invasive and non-invasive glucose monitoring is also attracting investment. While several emerging technologies remain subject to clinical and regulatory requirements, their potential to reduce fingersticks and improve long-term adherence is creating opportunities for future market growth.

Integration With Digital Health Platforms

Glucose monitoring is increasingly becoming part of broader digital diabetes-management ecosystems. CGM data can be integrated with behavioral coaching, insulin-delivery systems, remote patient monitoring platforms, and other digital therapeutics to provide more actionable information to patients and clinicians.

This integration is encouraging companies to compete not only through sensor accuracy but also through software, data analytics, connectivity, and patient-support services. Partnerships between medical-device companies, pharmaceutical companies, technology providers, and digital health platforms are further supporting this trend.

Affordability and Price Competition Remain Challenges

Despite strong demand, affordability remains a significant restraint for the blood glucose monitoring market. CGM systems can be expensive for patients without adequate insurance coverage, limiting adoption across lower-income populations and emerging markets.

At the same time, generic test strips are creating pricing pressure in the self-monitoring blood glucose segment. Manufacturers are therefore increasingly differentiating their products through connected features, digital coaching, subscription models, and integrated patient-management services.

Blood Glucose Monitoring Market Segmentation

By Device

• Self-Monitoring Blood Glucose

• Glucometers

• Test Strips

• Lancets & Lancing Devices

• Continuous Glucose Monitoring

• Sensors

• Transmitters & Receivers

Self-monitoring blood glucose currently represents a substantial portion of the market, supported by its established installed base and recurring demand for test strips. However, continuous glucose monitoring is expanding at a faster pace as reimbursement improves and connected sensor technologies gain acceptance.

By End User

• Hospitals & Clinics

• Homecare Settings

• Diagnostic Laboratories

Homecare settings account for the largest share of the market as diabetes management increasingly shifts outside traditional clinical environments. Remote monitoring and connected devices are supporting greater use of glucose-monitoring products in home-based care.

By Patient Type

• Type 1 Diabetes

• Type 2 Diabetes

• Gestational & Other Types

Type 2 diabetes represents the dominant patient group, supported by its large global patient population. Type 1 diabetes remains an important source of demand for advanced CGM systems and hybrid closed-loop technologies, while gestational diabetes represents an emerging application area.

By Distribution Channel

• Institutional Sales

• Retail Pharmacies

• Online Sales

Retail pharmacies and institutional channels remain important distribution routes, while online sales are gaining momentum as manufacturers expand direct-to-consumer models and subscription-based sensor delivery.

By Geography

• North America: United States, Canada, and Mexico

• Europe: Germany, United Kingdom, France, Italy, Spain, and Rest of Europe

• Asia-Pacific: China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific

• Middle East & Africa: GCC, South Africa, and Rest of Middle East & Africa

• South America: Brazil, Argentina, and Rest of South America

Blood Glucose Monitoring Market Competitive Landscape

The blood glucose monitoring market share is moderately concentrated, with established medical-device companies competing across both continuous and self-monitoring technologies. Abbott, Dexcom, and Medtronic have strong positions in CGM, while the SMBG segment includes a broader group of established and regional manufacturers.

Key Players

• Abbott Laboratories (Diabetes Care)

• Dexcom Inc.

• Medtronic PLC

• LifeScan Inc.

• F. Hoffmann-La Roche Ltd

• ACON Laboratories Inc.

• Agamatrix Holdings

• ARKRAY Inc.

• Ascensia Diabetes Care

• Biolinq Incorporated

• Bionime Corporation

• Insulet Corporation

• MicroPort Life Sciences

• Nipro Corporation

• Nova Biomedical

• Senseonics Holdings

• Sinocare Inc.

• Tandem Diabetes Care

• Trividia Health

• WaveForm Technologies

• Ypsomed Holding AG

Companies are focusing on smaller sensors, longer wear times, connected monitoring, digital coaching, integrated insulin-management systems, and new approaches to minimally invasive glucose measurement. These strategies are expected to influence the competitive positioning of participants across the blood glucose monitoring industry.

For more insights on the Japanese market report, please visit the Mordor Intelligence page: https://www.mordorintelligence.com/ja/industry-reports/global-blood-glucose-monitoring-market-industry?utm_source=abnewswire

Conclusion

The blood glucose monitoring market forecast indicates sustained growth as diabetes prevalence increases and healthcare systems place greater emphasis on continuous disease management. The transition toward CGM, connected devices, wearable sensors, and home-based monitoring is creating new opportunities beyond conventional fingerstick-based testing.

North America is expected to maintain its leading position, supported by established reimbursement mechanisms, healthcare infrastructure, and high adoption of connected glucose-monitoring technologies. Asia-Pacific is projected to record the fastest growth as diabetes screening expands, reimbursement improves, and manufacturers introduce more affordable monitoring solutions.

About Mordor Intelligence

Mordor Intelligence is a global market intelligence firm, founded in 2014, helping businesses make informed decisions through data-driven insights, industry expertise, and advanced analytics. With 550+ domain experts and on-ground specialists across 150+ countries, the company delivers comprehensive intelligence across aerospace & defense, agriculture, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, and logistics.

Its offerings include syndicated industry reports and subscription platforms such as Synapse. Mordor Intelligence is ISO 9001:2015 and ISO/IEC 27001:2022 certified, a member of ESOMAR and the Market Research Society of India, and a four-time Great Place to Work® honoree. Learn more at mordorintelligence.com.

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email: Send Email
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/